Sema4

Jul 29, 2020

Sema4 Raises $121M in Series C Financing Round

BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.

Jul 15, 2020

Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

The firm said the New York State approval for the two tests comes soon after it launched Sema4 Signal, a family of precision oncology products and services.

Jun 01, 2020

Sema4 Forms Coronavirus Testing Alliance With Connecticut

Sema4 said it will provide SARS-CoV-2 viral and antibody testing to Connecticut residents including state employees and first responders.

May 22, 2020

People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More

Mar 02, 2020

Sema4, VieCure Ink Precision Oncology Partnership

Researchers will use the VCurePrecision EMR platform to improve understanding of cancer, and doctors can use it make care decisions for patients.

Nov 15, 2019

New Products Posted to GenomeWeb: NuProbe, Personalis, CBR, More

Aug 29, 2019

Sema4 Lands New Investors, Continues to Expand

Premium

The firm did not disclose the size of the funding, which is helping it build on its Centrellis Health Intelligence Platform and move to whole-exome sequencing.

Breaking News

The Scan

And Maybe Not

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Now Onto a Hungry Caterpillar

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

This Variant Here

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

Nature Papers Present Tool for Topological Analysis of Chromosomes, Map of Genome-Lipid Associations

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.

Menu